BCG vaccine more effective than previously thought

The BCG vaccine has been found to be more effective against the most common form of tuberculosis than previously thought, according to a new study in Clinical Infectious Diseases.

Bacillus Calmette Guérin (BCG) is included in the childhood vaccination programme of many countries, and is the only licensed vaccine against (TB). However, it has previously been thought to only be effective against the less common forms of the disease that occur away from the lungs. Its efficacy against pulmonary TB, found in the lungs and by far the greatest burden of TB, has varied widely depending on location, ranging from 0% in South India to 80% in the UK.

In order to better understand the reason behind this variability, researchers led by the London School of Hygiene & Tropical Medicine conducted a systematic review of global literature on all reported BCG trials across 10 medical electronic databases, looking at the factors affecting its level of protection against pulmonary TB.

The research shows for the first time that the BCG vaccine is actually highly protective against pulmonary TB in all parts of the world, including significant protection when administered in the tropics.

The main reason for the apparent variation in protection against disease seen in previous studies was found to be due to prior infection reducing the efficacy of the vaccine. BCG vaccination for those with no history of prior TB infection, including young infants, showed a much higher efficacy against pulmonary TB.

The study therefore highlights a new role for BCG in fighting pulmonary TB, a need for early vaccination, and further suggests that any new TB vaccine based on BCG will also need to be administered before infection has occurred.

Lead author Dr Punam Mangtani, Clinical Senior Lecturer in Epidemiology at the London School of Hygiene & Tropical Medicine, said: "This research corrects a longstanding misconception that BCG is ineffective against pulmonary disease, and confirms its importance in controlling the major burden from TB and main source of transmission in all settings. Now that we know previous infection can lower the protection provided by the vaccine, it is important that BCG is given as early as possible in a person's life, and ideally immediately after birth."

add to favorites email to friend print save as pdf

Related Stories

Scientists find candidate for new TB vaccine

Mar 18, 2011

Scientists have discovered a protein secreted by tuberculosis (TB) bacteria that could be a promising new vaccine candidate, they report today in Proceedings of the National Academy of Sciences. The protein could also be use ...

New tuberculosis research movement needed

Nov 30, 2011

In this week's PLoS Medicine, Christian Lienhardt from the WHO in Geneva, Switzerland and colleagues announce that the Stop TB Partnership and the WHO Stop TB Department have launched the TB Research Movement.

Experimental vaccine shows promise against TB meningitis

Jun 11, 2013

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately ...

Recommended for you

Travel restrictions could worsen Ebola crisis: experts

2 hours ago

Travel restrictions could worsen West Africa's Ebola epidemic, limiting medical and food supplies and keeping out much-needed doctors, virologists said Tuesday as the disease continued its deadly spread.

World 'losing battle' to contain Ebola: MSF (Update)

3 hours ago

International medical agency Medecins sans Frontieres said Tuesday the world was "losing the battle" to contain Ebola as the United Nations warned of severe food shortages in the hardest-hit countries.

Mutating Ebola viruses not as scary as evolving ones

3 hours ago

My social media accounts today are cluttered with stories about "mutating" Ebola viruses. The usually excellent ScienceAlert, for example, rather breathlessly informs us "The Ebola virus is mutating faster in humans than in animal hosts ...

War between bacteria and phages benefits humans

4 hours ago

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages. In a new study, researchers from Tufts University, Massachusetts ...

Ebola kills 31 people in DR Congo: WHO

6 hours ago

An outbreak of the Ebola virus in the Democratic Republic of Congo has killed 31 people and the epidemic remains contained in a remote northwestern region, UN the World Health Organization (WHO) said Tuesday.

User comments